![](https://library.celltelligence.com/wp-content/uploads/2021/05/Bayer_Takeda.png)
$0
Spotlight on Bayer’s and Takeda’s Cell Therapy Strategy Part I
As Bayer continues to invest and expand into the cell therapy space, the Celltelligence team provides an analysis below on Bayer’s possible strategy, manufacturing technology, and partnerships. In a subsequent part 2 blast, the Celltelligence team will provide a similar overview for Takeda, who appears to be pursuing a similar cell therapy approach.